Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Kinetic Partners comments on draft UCITS V directive

Friday, July 20, 2012

Beverly Chandler, Opalesque London: Kinetic Partners Dublin based member Killian Buckley has commented on the recent publication of the EC’s proposed amendments to the UCITS Directive. Buckley finds that the average investor might feel a little overwhelmed with the regulatory protection pouring down on his or her head at the moment, as investors await the final AIFMD incarnation and has the amended directive to deal with.

Buckley finds that retail investor protection lies at the centre of the proposed amendments, taking UCITS right back to where it started, as a retail product. The Directive covers three areas: depositaries; UCITS Management Company remuneration policies and sanctions for breaches of UCITS law.

Buckley writes: "Depositary duties have been notoriously difficult to define, with European countries sometimes having wildly divergent views on its depositaries role and responsibilities. Effectively, the Commission now wants to be able to compare apples with apples and move to a harmonised, consistent and codified interpretation of the Directive. Laudable indeed; however, the effect, particularly in the political goldfish bowl of current regulatory ini......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its